deltatrials
Completed OBSERVATIONAL NCT04845269

Post-Stroke Osteopathy

Post-Stroke Osteopathy: Characterization of Fractures and Changes in the Bone Microstructure After Ischemic Stroke or TIA

Sponsor: Medical University Innsbruck

Updated 7 times since 2021 Last updated: Jun 21, 2023 Started: Mar 31, 2021 Primary completion: May 31, 2023 Completion: May 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04845269, this observational or N/A phase trial focuses on Fall and Fracture and remains completed. Sponsored by Medical University Innsbruck, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2021 – ~Dec 2021 · 7 months · monthly snapshotRecruiting~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Jul 2023 · 12 months · monthly snapshotActive Not Recruiting~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jul 2023 — Jul 2024 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  4. Jul 2022 — Jul 2023 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  5. Apr 2022 — Jul 2022 [monthly]

    Recruiting

Show 2 earlier versions
  1. Dec 2021 — Apr 2022 [monthly]

    Recruiting

  2. May 2021 — Dec 2021 [monthly]

    Recruiting

    First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medical University Innsbruck
  • VASCage GmbH
Data source: VASCage GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations